Heron Therapeutics HRTX
Heron Therapeutics Announces Second Quarter 2026 Financial Results
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001193125-26-341300
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Zevra Therapeutics ZVRA
- Amarin AMRN
- Verastem VSTM
- Actinium Pharmaceuticals ATNM
- KalVista Pharmaceuticals KALV
